LSE:RENE (ReNeuron Group)

About RENE

ReNeuron Group PLC is engaged in the field of biotechnology. Its core activities include the research and clinical development of cell-based therapeutics. The company product pipeline includes human retinal progenitor cell line (hRPC) and CTX neural cell line. It derives revenue from UK and US. The company is mainly focusing on the treatment of stroke disability, inherited retinal diseases, and cancer.
  • Should you invest £1,000 in Centaur Media Plc right now?

    When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

    Mark and his analyst team just revealed what they believe are the 6 best stocks for investors to buy right now... and Centaur Media Plc wasn’t on the list. Right now, they think there are 6 stocks that are better buys!

    See the 6 stocks